Methyl iodide → HCID 87619625, Verbindung

HRID 2111419Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2111419
[CH2:1]([N:4]1[CH2:10][CH:9]([CH3:11])[C:8](=[O:12])[NH:7][C:6]2[CH:13]=[N:14][C:15]([Cl:17])=[N:16][C:5]1=2)[CH:2]=[CH2:3].I[CH3:19].[H-].[Na+]>CN(C)C=O>[CH2:1]([N:4]1[CH2:10][CH:9]([CH3:11])[C:8](=[O:12])[N:7]([CH3:19])[C:6]2[CH:13]=[N:14][C:15]([Cl:17])=[N:16][C:5]1=2)[CH:2]=[CH2:3]

Komponenten

5

Versuchsvorschrift

To a mixture of 1.37 g (0.00542 mole) of (rac)-9-allyl-2-chloro-7-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VI-65), 0.51 mL (0.00813 mole) of iodomethane and 15 mL of N,N-dimethyl-formamide at 0 degrees, was added 0.33 g (0.00813 mole) of 60% oil dispersion of sodium hydride. The mixture was stirred at 0 degrees for 2 hours and then partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate. The combined organic phases were washed successively with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography, eluting with hexanes-ethyl acetate (100:0-60:40) to give 1.45 g of (rac)-9-allyl-2-chloro-5,7-dimethyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-65). HRMS (ES+) m/z Calcd for C12H15CIN4O+H [(M+H)+]: 267.1007. Found: 267.1007.

Aufarbeitung

  1. custompartitioned between ethyl acetate and water
  2. extractionThe aqueous phase was extracted with ethyl acetate
  3. washThe combined organic phases were washed successively with water and brine
  4. dry with materialdried over anhydrous magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated under reduced pressure
  7. customThe residue was purified by silica gel chromatography
  8. washeluting with hexanes-ethyl acetate (100:0-60:40)

Quellen und Nachweise

ORD-Eintrag
ord-4a9088b1f4a845589c02df7f160d3167
Quelldatensatz
uspto-grants-2009_04
Patentnummer
US07517873B2

Notizen zur Reaktion

Wird geladen…